Regeneron suspends COVID-19 antibody trial among sickest patients
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its COVID-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
Oct 30, 2020
0
7